Drug Channels 09月29日
罕见病药房模式应对挑战
index_new5.html
../../../zaker_core/zaker_tpl_static/wap/tpl_guoji1.html

 

本文探讨了PANTHERx Rare公司CEO Bansi Nagji提出的“罕见病药房”模式如何解决罕见病给患者、护理者和医疗体系带来的挑战,强调了超个性化、同理心和数据在改善罕见病个体患者结果中的作用。
Today’s guest post comes from Bansi Nagji, Chief Executive Officer at PANTHERx Rare.

Bansi explores how the emerging model of “Rare Pharmacy” addresses the challenges rare diseases pose to patients, caregivers, and the healthcare system. His perspective highlights the role of hyper-personalization, empathy, and data in improving outcomes for individuals with rare and orphan conditions, while also pointing to lessons that may extend across the broader healthcare landscape.

Click here to learn more about PANTHERx’s approach to hyper-personalization.

Read on for Bansi’s insights.
Read more »

© 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute, an HMP Global Company. All rights reserved. This Feed is for personal non-commercial use only.

Fish AI Reader

Fish AI Reader

AI辅助创作,多种专业模板,深度分析,高质量内容生成。从观点提取到深度思考,FishAI为您提供全方位的创作支持。新版本引入自定义参数,让您的创作更加个性化和精准。

FishAI

FishAI

鱼阅,AI 时代的下一个智能信息助手,助你摆脱信息焦虑

联系邮箱 441953276@qq.com

相关标签

罕见病 药房模式 个性化医疗
相关文章